51524-84-6Relevant academic research and scientific papers
Infrared spectra and molecular structure. Part II. N-methyl- and N, N-dimethylaminobenzoic acids
Rao,Jose
, p. 447 - 456 (1973)
Infrared spectra of N-methyl- and N,N-dimethylaminobenzoic acids have been investigated. All the acids except N,N-dimethylanthranilic acid showed neutral structures in the solid state. The N,N-dimethylanthranilic acid, however, exhibited a dipolar structure with strong intramolecular hydrogen bonding in the solid state while in solution it is neutral.
PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
Saavedra, Joseph E.,Srinivasan, Aloka,Buzard, Gregory S.,Davies, Keith M.,Waterhouse, David J.,Inami, Keiko,Wilde, Thomas C.,Citro, Michael L.,Cuellar, Matthew,Deschamps, Jeffrey R.,Parrish, Damon,Shami, Paul J.,Findlay, Victoria J.,Townsend, Danyelle M.,Tew, Kenneth D.,Singh, Shivendra,Jia, Lee,Ji, Xinhua,Keefer, Larry K.
, p. 1157 - 1164 (2006)
PABA/NO is a diazeniumdiolate of structure Me2NN(O)=NOAr (where Ar is a 5-substituted-2,4-dinitrophenyl ring whose 5-substituent is N-methyl-p-aminobenzoic acid). It has shown activity against human ovarian cancer xenografts in mice rivaling th
4-HYDROXPIPERIDINE DERIVATIVE WITH ANALGETIC ACTIVITY
-
Page 27, (2010/11/30)
A compound represented by the following Formula (I): (wherein A represents oxygen atom or -NR3- (R3 represents hydrogen atom or lower alkyl group); R1 represents nitro group, lower alkoxycarbonyl group, carbamoyl group unsubstituted or mono- or di-substituted by lower alkyl group, unprotected or protected hydroxyl group, unprotected or protected carboxyl group, lower alkyl group substituted by unprotected or protected hydroxyl group, or tetrazolyl group; and R2 represents hydrogen atom, cyano group or lower alkylsulfonyl group, provided that when A is - NR3-, it is excluded that R1 represents unprotected or protected hydroxyl group or lower alkyl group substituted by unprotected or protected hydroxyl group) or its salt, and method for producing the compound, and a pharmaceutical composition containing the compound as active ingredient.
3-(substituted phenyl)phthalides
-
, (2008/06/13)
Process comprises the combination of the three steps of condensing 3-N(R)2 -4-X-benzoic acid with an aromatic or heterocyclic aldehyde, Y-CHO, under acidic conditions to produce 3-Y-5-X-6-N(R)2 phthalide (II), condensing said phthalide with a compound of the formula Z-H under alkaline or acid conditions to produce 2-(α-Y-α-Z)methyl-4-X-5-N(R)2 benzoic acid (III), and oxidizing said benzoic acid to produce 3-Y-3-Z-5-X-6-N(R)2 phthalide (I) where: R is hydrogen, non-tertiary alkyl of one to four carbon atoms, benzyl or substituted benzyl; X is hydrogen or halo; Y is 4-R1 -3-R2 -2-R1 -phenyl, 1-R5 -2-R6 -5/6-R4 -3-indolyl, 9-R7 -3-carbazolyl, 9-julolidinyl, 3,4-dioxymethylenephenyl, 2-thienyl, 1-R8 -2-pyrrolyl, or 4-pyridinyl; and Z is 4-R1 -3-R2 -2-R1 -phenyl, 1-R5 -2-R6 -5/6-R4 -3-indolyl or 1-R8 -2-pyrrolyl which are useful as colorless precursor color formers in carbonless duplicating and in thermal marking systems. The intermediates, 3-Y-5-X-6-N(R)2 phthalides (II) and 2-(α-Y-α-Z)methyl-4-X-5-N(R)2 benzoic acids (III) also have utility as colorless precursor color formers in carbonless duplicating and thermal marking systems.
